Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Zydus Lifesciences Ltd

NSE: ZYDUSLIFE · BSE: 532321 · Pharmaceuticals & Biotechnology · 68 announcements

Zydus Lifesciences Ltd news stories on ALFA NewsRead the news →
Share price
₹1,153.00
Market cap
₹1,16,019 Cr
Revenue (annual)
₹27,148 Cr
Net profit (annual)
₹5,040 Cr
P/E (TTM)
25.7×Sector 47.4×
Promoter holding
75.01%+0.01% QoQ
FII holding
6.89%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

10:27 IST NSE
Adverse Business Impact

Zydus Lifesciences Adverse Business Impact

Zydus Lifesciences received a USFDA Warning Letter regarding its Baddi facility's purified talc technical observations. The company expects no impact on current operations or supplies.